home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Releasing Immune Cells From The Bone Marrow

  February, 14 2006 10:56
your information resource in human molecular genetics
A new function of chemical signals called 'chemokines' is revealed in a study in the March issue of Nature Immunology.

Chemokines were previously believed to function solely as guides for immune cells moving from the circulation to tissues, but this new research shows that chemokines can also cause the release of immune cells from niches such as the bone marrow.

Studies on chemokine function have focused on their role in attracting immune cells, such as inflammatory monocytes, to specific sites in the body. Homing of monocytes to the spleen during infection, for example, was previously thought to occur by chemokine attraction of monocytes that express the protein CCR2, a chemokine-responsive molecule on the surface of the cells. Work by Serbina and Pamer instead shows that monocytes require CCR2 for release from bone marrow niches where they are produced. After release into the circulation, the cells travel to the spleen without further requirement for CCR2.

These new data identify a previously unknown function for chemokines as 'gatekeepers' in addition to their known function in controlling the movement of immune cells.

Author contacts:

Dr. Natalya Serbina (Memorial Sloan-Kettering Institute, NY USA)
Email: serbinan@mskcc.org

Dr. Eric G. Pamer (Memorial Sloan-Kettering Institute, NY USA)
Email: pamere@mskcc.org

Additional contact for comments on paper:

Dr. Barrett Rollins (Dana Farber Cancer Institute, Boston, MA, USA)
E-mail: barrett_rollins@dfci.harvard.edu

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.